The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of vorinostat with concurrent chemoradiotherapy (CRT) for locally advanced non-squamous non-small cell lung cancer (NSCLC).
 
Ranee Mehra
Employment - GlaxoSmithKline (I)
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech; Novartis
Research Funding - Genentech
 
Aruna Turaka
No Relationships to Disclose
 
Joshua E. Meyer
Honoraria - InSightec
 
Brian L. Egleston
No Relationships to Disclose
 
Tawee Tanvetyanon
No Relationships to Disclose
 
Mary Colleen Pinder
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Consulting or Advisory Role - Genentech; Myriad Pharmaceuticals
Speakers' Bureau - Genentech
Research Funding - Pfizer
 
Thomas J. Dilling
No Relationships to Disclose
 
Charles C. Williams
No Relationships to Disclose
 
Jhanelle Elaine Gray
Consulting or Advisory Role - Lilly
Research Funding - Lilly
 
Keisuke Shirai
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline
Speakers' Bureau - Bristol-Myers Squibb
 
R. Katherine Alpaugh
No Relationships to Disclose
 
Debbie Riordan
No Relationships to Disclose
 
Neeta Somaiah
No Relationships to Disclose
 
Prashant C. Shah
Employment - Roche Pharma AG (I)
 
Walter Joseph Scott
No Relationships to Disclose
 
George R. Simon
No Relationships to Disclose
 
Hossein Borghaei
Honoraria - Bristol-Myers Squibb; Celgene
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Genentech; Lilly
Research Funding - Millennium (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Genentech; Lilly